SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-360963
Filing Date
2018-12-28
Accepted
2018-12-28 16:19:53
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d665127d424b5.htm 424B5 428955
2 GRAPHIC g665127g44w94.jpg GRAPHIC 170697
3 GRAPHIC g665127g70x59.jpg GRAPHIC 141678
4 GRAPHIC g665127g79e39.jpg GRAPHIC 37793
  Complete submission text file 0001193125-18-360963.txt   912817
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-226266 | Film No.: 181257629
SIC: 2834 Pharmaceutical Preparations